反応式
Cl[C:2]1[O:3][C:4]([C:7]2[CH:12]=[CH:11][C:10]([C:13]([F:16])([F:15])[F:14])=[CH:9][CH:8]=2)=[CH:5][N:6]=1.[NH2:17][C:18]1[CH:19]=[C:20]([NH:24][S:25]([CH2:28][C:29]2[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=2)(=[O:27])=[O:26])[CH:21]=[CH:22][CH:23]=1>CC(O)C>[C:29]1([CH2:28][S:25]([NH:24][C:20]2[CH:21]=[CH:22][CH:23]=[C:18]([NH:17][C:2]3[O:3][C:4]([C:7]4[CH:12]=[CH:11][C:10]([C:13]([F:16])([F:15])[F:14])=[CH:9][CH:8]=4)=[CH:5][N:6]=3)[CH:19]=2)(=[O:26])=[O:27])[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=1参加物
4
反応条件
- 温度
- 80 °C
実験手順
A mixture of 2-chloro-5-(4-(trifluoromethyl)phenyl)oxazole 31 (0.651 g, 2.63 mmol) and N-(3-aminophenyl)-1-phenylmethanesulfonamide 26 (0.69 g, 2.63 mmol) in 2-propanol (50 mL) was heated to 80° C. for 18 h with stirring. Upon cooling, solvent was evaporated and silica column purified (Biotage) (Acetone/hexane as an eluent) to provide 1-phenyl-N-(3-((5-(4-(trifluoromethyl)phenyl)oxazol-2-yl)amino) phenyl) methane sulfonamide. 34 (0.407 g, 33% yield) as a solid. MS (ES) m/z 474 (M+H+).
後処理
- temperatureUpon cooling
- customsolvent was evaporated
- customsilica column purified (Biotage) (Acetone/hexane as an eluent)
出典と根拠
- ORDレコード
- ord-f52227b5f0b2481287114cf7e02f9353
- 出典データセット
- uspto-grants-2014_10
- 特許番号
- US08865709B2
関連ノート
読み込み中…